New York Post26d
Stanley recalls 2.6M mugs after dozens suffer burn injuries caused by faulty lids
Stanley, the brand name whose cups became a cultural phenomenon in recent years thanks to the viral trend on TikTok, is recalling 2.6 million mugs due to dozens of people suffering burn injuries ...
Nasdaq18d
Spotlight on Humacyte: Analyzing the Surge in Options Activity
Financial giants have made a conspicuous bearish move on Humacyte. Our analysis of options history for Humacyte (NASDAQ:HUMA) revealed 9 unusual trades. Delving into the details, we found 11% of ...
Nasdaq19d
Humacyte, Inc. Announces FDA Approval for SYMVESS as First-in-Class Bioengineered Vascular Conduit for Arterial Injury Repair
Humacyte, Inc. has announced that the FDA has granted full approval for SYMVESS, a novel bioengineered human tissue designed for use as a vascular conduit in patients with extremity arterial ...
Business Insider24d
Humacyte, Inc. Is Being Sued For Violating Securities Laws And Investors With Losses Are Invited To Contact The Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Humacyte, Inc. ("Humacyte" or "the Company") (NASDAQ:HUMA) for violations of ...
The Business Journals18d
FDA approval propels North Carolina company's breakthrough treatment for trauma patients
STORY HIGHLIGHTS FDA approved Humacyte's Symvess for vascular trauma treatment. Symvess is a bioengineered human tissue vascular conduit. Humacyte plans commercial launch and technology expansion.